WH Hauss Prize

The German Society for Angiology and Rheumatology (DGAF) awards the WH Hauss Prize annually to young scientists within the society to promote their scientific work in the field of arteriosclerosis research. The prize is endowed with €3,000 and is awarded at the annual conference. This prize money is made possible by the generous donation of Prof. Winfried März, to whom we extend our sincere thanks.

Scientists (under 40 years of age) who are members of the German Society for Arteriosclerosis Research (DGAF) are eligible to apply for the prize. Only one original scientific publication (no reviews or dissertations) may be submitted. The publication may cover any area of arteriosclerosis research and must have been published online or accepted for publication by the application deadline (December 31st). In cases of shared first authorship, the authors must apply jointly and, if selected, will be jointly awarded the prize. The prize money will be divided accordingly and paid separately to the recipients. Works that have already received other awards or have been submitted for other prizes are not eligible.

The work should be submitted along with a brief cover letter and the applicant's academic career (max. 1 page). Please submit your application as a single PDF document to the following address: info@dgaf.de

Checklist:

a) Membership in the DGAF at the time of application

b) No submission for the award should be made elsewhere.

A PDF document containing

c) the original work to be awarded

d) if not yet publicly available: proof of acceptance for publication

e) Brief academic career of the applicant(s) (max. 1 page)

f) Proof of age (< 40 years on the cut-off date (31.12.))

Preisträger und Preisvorträge

2026

Nicolas Hense, Dr. Andrea Gorgels, Dr. Bilal Mir, Aachen

1-phosphatidylinositol 3-phosphate 5-kinase inhibition by Apilimod promotes an adipocytelike vascular smooth muscle cell phenotype and prevents arterial calcification

2025

Hauke Horstmann (Freiburg) & Nathaly Anto Michel (Graz) & Xia Sheng (Freiburg)

Cross-species single-cell RNA sequencing reveals divergent phenotypes and activation states of adaptive immunity in human carotid and experimental murine atherosclerosis

2024

Kein Hauss Preis vergeben/Hauss Award not conferred

2023

Sarajo Mohanta (München)

Neuroimmune cardiovascular interfaces control atherosclerosis

2022
Silvia di Maio (Innsbruck)

Lipoprotein(a) and SARS-CoV-2 infections: susceptibility to infections, ischemic heart disease and thromboembolic events 

2021

Ben Kappel (Aachen)

Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis developement after antibiotics treatment

2020

Sylvia Mas (Frankfurt a.M.)

Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation

2019

Dennis Wolf (Freiburg)

Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry

2018
Yvonne Döring (München) & Heidi Noels (Aachen)
Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence from Mouse and Human Studies

2017
Claudia Göttsch (Aachen)
Sortilin mediates vascular calcification via its recruitment into extracellular vesicles

2016
Rory Koenen (Maastricht)
Hyperreactivity of junctional adhesion molecule A‐deficient platelets accelerates atherosclerosis in hyperlipidemic mice

2015
Ingo Hilgendorf (Freiburg)
Innate Response Activator B cells aggravate atherosclerosis by stimulating TH1 adaptive immunity

2014
Sakine Simsekyilmaz (Aachen) und Hector A. Cabrera-Fuentes (Giessen)
The Role of Extracellular RNA in Atherosclerotic Plaque Formation in Mice

2013
S. Zügel (Ulm)
Growth Differentiation Factor-15 Deficiency Inhibits Atherosclerosis Progression by Regulating Interleukin-6–Dependent Inflammatory Response to Vascular Injury

2011
B. Schieffer (Hannover):
Inflammation and immunmodulation in atherosclerotic plaque development – from mice and man

2009
Karina Reiß (Kiel):
ADAM10 regulates endothelial permeability and T-cell transmigration by proteolysis of vascular endothelial cadherin

2008
C. Weber (Aachen):
Chemokin-artige Funktionen von MIF in der Atherosklerose

2007
P. Kleinbongard (Aachen):
Erste Aspekte zur Aktivität und Funktion der erythrozytären NOS in Patienten mit kardiovaskulären Erkrankungen

2006
A.E. May, R. Schmidt (Tübingen):
Neue Aspekte zur Regulierung der Inflammation bei Atherosklerose und Myokardinfarkt

2005
Michael Torzewski, S. Bhakdi (Mainz):
C-reaktives Protein und Atherosklerose – Modulation der Komplementaktivierung als potentielles antiatherogenes Prinzip

2004
G. Plenz (Münster):
GM-CSF und die vaskuläre extrazelluläre Matrix: Bedeutung für Gefäßwandintegrität, Plaquestablilität und Restenose.
T. Chavakis (Heidelberg):
RAGE-vermittelte Rekrutierung von inflammatorischen Zellen: Ein Mechanismus für die akzelerierte Atherosklerose beim Diabetes?

2003
C. Urbich (Frankfurt):
Inhibitorische Effekte des CD40 Liganden auf die Endothelzell-Migration und Angiogenese.

2002
K. Dugi (Heidelberg):
Triglyzeridstoffwechsel und Atherosklerose.
B. Levkau (Münster):
Signalwege der Anti-Apoptose in vaskulären Endothelzellen: Die Rolle endogener Caspaseinhibitoren der IAP-Proteinfamilie.

2001
Ch. Viedt (Heidelberg):
Die proinflammatorische Wirkung des terminalen Komplementkomplexes bei der Arteriosklerose

2000
Niko Marx (Ulm):
PPAR-Aktivierung und antiinflammatorische Wirkung in Endothelzellen

1999
Ralf Kinscherf, H.-P. Deigner (Heidelberg):
Apopotosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent

1998
J.-R. Nofer (Münster):
Neue Erkenntnisse zur Interaktion zwischen Lipoproteinen und Thrombozyten

1997
J. Pietzsch (Dresden):
In vivo Stoffwechsel ApoB-100-haltiger Lipoproteine bei familiärem defektem Apolipoprotein B-100 (FDB)

1996
C. Ihling (Freiburg):
Endothelin-1-Immunoreaktivität bei humaner Coronarsklerose: Eine detaillierte Analyse der zellulären Verteilung von Endothelin 1

1995
Arnold von Eckardstein (Münster):
Die Rolle von Apolipoprotein E für den reversen Cholesterintransport

1994
B. S. Oemar, T. Lüscher (Bern):
Differential clonig and expression of human connective tissue growth factor

1993
D. Kling (Tübingen):
Leukozyteninvasion bei experimenteller Arteriosklerose und ihre funktionelle Bedeutung für die Migration glatter Muskelzellen

1992
H. A. Lehr (München):
Stimulation der Leukozyten/Endothel Interaktion durch oxidativ modifizierte low density Lipoproteine: Mechanismen, Lokalisation, Rezeptorbeteiligung